At a glance
ClinicalIndex Comparison RecordN/ACompleted· 677 enrolled
Drug / intervention
AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric IOL +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Investigation of AcrySof® IQ ReSTOR® Multifocal Toric Intraocular Lens Models SND1T3/ SND1T4/ SND1T5/ SND1T6
In Brief
A clinical study evaluating AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric IOL and AcrySof® ReSTOR® Multifocal IOL Model SA60D3 for Cataracts. Completed, enrolled 677 participants.
Detailed Summary
The purpose of this study is to evaluate the safety and effectiveness of an investigational multifocal toric intraocular lens (IOL) compared to an FDA-approved multifocal IOL.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataracts
Countries--
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2011
First PostedAug 2011
Primary CompletionJan 2013
TodayJul 2026
First PostedAug 26, 2011
Enrollment StartJul 1, 2011
Primary CompletionJan 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 14.8 years ago
Interventions
AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric IOLdevice
Multifocal IOL with extended secondary focal point and astigmatism correction implanted for long-term use over the lifetime of the cataract patient
AcrySof® ReSTOR® Multifocal IOL Model SA60D3device
Multifocal IOL with extended secondary focal point implanted for long-term use over the lifetime of the cataract patient